Veritas Investment Management LLP increased its holdings in UnitedHealth Group Inc (NYSE:UNH) by 2.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 456,526 shares of the healthcare conglomerate’s stock after purchasing an additional 12,055 shares during the quarter. UnitedHealth Group makes up approximately 12.1% of Veritas Investment Management LLP’s holdings, making the stock its largest holding. Veritas Investment Management LLP’s holdings in UnitedHealth Group were worth $89,388,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Jennison Associates LLC grew its stake in shares of UnitedHealth Group by 146.0% in the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after purchasing an additional 3,289,470 shares during the last quarter. Janus Henderson Group PLC boosted its position in UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after acquiring an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. boosted its position in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after acquiring an additional 1,588,516 shares in the last quarter. Parametric Portfolio Associates LLC boosted its position in UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after acquiring an additional 1,562,661 shares in the last quarter. Finally, Thrivent Financial For Lutherans boosted its position in UnitedHealth Group by 346.7% during the 2nd quarter. Thrivent Financial For Lutherans now owns 1,690,187 shares of the healthcare conglomerate’s stock valued at $313,394,000 after acquiring an additional 1,311,773 shares in the last quarter. 86.01% of the stock is currently owned by institutional investors.

In related news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the transaction, the director now directly owns 61,137 shares in the company, valued at approximately $13,652,503.47. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock valued at $7,669,416 over the last quarter. Company insiders own 0.89% of the company’s stock.

Several analysts have weighed in on the company. Evercore ISI reaffirmed an “outperform” rating and set a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a research report on Friday. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Oppenheimer lifted their price objective on UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research report on Wednesday, October 18th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $208.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 17th. Finally, Morgan Stanley lifted their price objective on UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $229.54.

UnitedHealth Group Inc (UNH) opened at $228.64 on Monday. UnitedHealth Group Inc has a 1-year low of $156.09 and a 1-year high of $231.77. The stock has a market cap of $221,060.00, a P/E ratio of 25.98, a PEG ratio of 1.56 and a beta of 0.66. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the business earned $2.17 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. sell-side analysts predict that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Veritas Investment Management LLP Has $89.39 Million Position in UnitedHealth Group Inc (UNH)” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/veritas-investment-management-llp-has-89-39-million-position-in-unitedhealth-group-inc-unh/1807895.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.